General MedicationsORAL-28Generic

MIRCETTE

DESOGESTREL; ETHINYL ESTRADIOL

Standard Dose

0.15MG,N/A;0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview MIRCETTE is listed in Drugs@FDA under application 020713 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-28 - 0.15MG,N/A;0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2023-01-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview MIRCETTE is listed in Drugs@FDA under application 020713 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-28 - 0.15MG,N/A;0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2023-01-04 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.